Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Radioterapi & Onkologi Indonesia
Harman Juniardi
Unknown Affiliation
Education Health Professions Medicine & Pharmacology Physics Other

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Patients Outcome with Brain Oligometastases Treated with the SIB-IMRT Technique: Dr. Kariadi General Hospital Experience Christina Hari Nawangsih; Harman Juniardi; Dion Firli; Sigit Wirawan; Sri Rahayu Subandini; Diaza Okadimar Ariyanto
Radioterapi & Onkologi Indonesia Vol 13, No 1 (2022): Volume 13 No.1 January 2022
Publisher : Perhimpunan Dokter Spesialis Onkologi Radiasi Indonesia (PORI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32532/jori.v13i1.142

Abstract

Brain metastases are often considered as the end of life in oncologic diseases. Previously, a standalone Whole Brain Radiotherapy (WBRT) had been the standard of care in the case of single or multiple lesions. Currently, Simultaneous Integrated Boost - Intensity Modulated Radiotherapy (SIB-IMRT) permits the delivery of simultaneous doses within a single therapy to the whole brain and the local lesion, therefore shifting the care expectation from palliative towards curative. This study summarizes the outcome in cancer patients with brain oligometastases that were treated with the SIB-IMRT technique. Between April 2020 and April 2021, a total of 29 brain oligometastases patients were treated with the SIB-IMRT technique at Dr. Kariadi General Hospital. Twenty patients completed treatment with a whole-brain dose of 37.5 Gy and tumor dose of 45 Gy, both in 15 fractions. Among fifteen who were successfully followed-up, six at the 6th-month follow-up, complete data of four patients were included. All four patients improved clinically. Evaluation from imaging revealed mass reductions in two patients, while one patient’s metastases were progressing, and the other one showed no changes. Additionally, no patients demonstrated cerebral necrosis as a late side effect.
Co-Authors Christina Hari Nawangsih Diaza Okadimar Ariyanto Dion Firli Sigit Wirawan Sri Rahayu Subandini